M&A Deal Summary

Innoviva Acquires La Jolla Pharmaceutical

On July 11, 2022, Innoviva acquired life science company La Jolla Pharmaceutical for 149M USD

Acquisition Highlights
  • This is Innoviva’s 2nd transaction in the Life Science sector.
  • This is Innoviva’s largest (disclosed) transaction.
  • This is Innoviva’s 2nd transaction in the United States.
  • This is Innoviva’s 2nd transaction in Massachusetts.

M&A Deal Summary
Date 2022-07-11
Target La Jolla Pharmaceutical
Sector Life Science
Buyer(s) Innoviva
Deal Type Add-on Acquisition
Deal Value 149M USD
Advisor(s) Cowen Group, Inc. (Financial)
Gibson, Dunn & Crutcher (Legal)

Target

La Jolla Pharmaceutical

Waltham, Massachusetts, United States
La Jolla Pharmaceutical is a biotechnology company involved in the development of therapeutics for lupus nephritis and other autoimmune diseases. La Jolla Pharmaceutical was founded in 1989 and is based in Waltham, Massachusetts.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Innoviva

Burlingame, California, United States
Category Company
Founded 1996
Sector Life Science
Employees112
Revenue 310M USD (2023)
DESCRIPTION

Innoviva is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development, and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Innoviva was founded in 1996 and is based in Burlingame, California.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Massachusetts) 2 of 2
Country (United States) 2 of 2
Year (2022) 2 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-23 Entasis Therapeutics

Waltham, Massachusetts, United States

Entasis Therapeutics is an advanced late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted antibacterial products that address high unmet medical needs to treat serious infections caused by multidrug-resistant pathogens. Entasis Therapeutics was founded in 2015 and is based in Waltham, Massachusetts.

Buy $113M
Mergr

Product

Company

Legal